Elepho Inc. – Trademark Portfolio

Entity Type: 03

Elepho Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ECLIP, ELEPHO, and ETHERM. The owner is based in Baltimore, MD.

466 Central Avenue

Baltimore, MD 21209

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ETHERM
ETHERM
Registered 2021
ECLIP
ECLIP
Registered 2017
ELEPHO
ELEPHO
Registered 2016

Trademark Classifications

Elepho Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Elepho Inc. have?

Elepho Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Elepho Inc. file in?

Elepho Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Elepho Inc.'s most well-known trademarks?

Elepho Inc.'s registered trademark portfolio includes well-known marks such as ECLIP, ELEPHO, and ETHERM. These are among 3 currently registered trademarks in the portfolio.

What is Elepho Inc.'s trademark registration success rate?

Elepho Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.